Varivax vaccine with diluents
Ended Awarded Last action
- Contract number
- SPE2DR26F0A5J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,964
Award facts
- Contract value 100% obligated
- $50,964.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,964 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, effective January 27, 2026, with an ultimate completion date of February 18, 2026, represents a non-competitive delivery order issued under a larger indefinite delivery contract vehicle. Performance will be executed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The IDC supports military healthcare programs worldwide and serves customers including the Defense Health Agency and U.S. Coast Guard. As a prime vendor under this flexible contract vehicle, AmerisourceBergen demonstrates established capability to fulfill essential pharmaceutical and medical supply requirements for federal military treatment facilities and healthcare programs through competitively awarded arrangements.
Quick answers
Who was awarded contract SPE2DR26F0A5J?
SPE2DR26F0A5J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F0A5J worth?
The government has obligated $50,964 on SPE2DR26F0A5J.
Is contract SPE2DR26F0A5J an order under another contract?
Yes. SPE2DR26F0A5J is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A5J competed?
The extent of competition for SPE2DR26F0A5J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award